Timber Pharmaceuticals, Inc.
TMBR · AMEX
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $623 | $436 | $307 | $1,048 |
| - Cash | $2,520 | $5,175 | $9,080 | $11,224 |
| + Debt | $545 | $625 | $331 | $420 |
| Enterprise Value | -$1,351 | -$4,114 | -$8,442 | -$9,757 |
| Revenue | $0 | $0 | $83 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$2,471 | -$2,366 | -$2,018 | -$1,791 |
| % Margin | – | – | -2,425.9% | – |
| EBITDA | -$3,910 | -$3,913 | -$3,466 | -$3,044 |
| % Margin | – | – | -4,166.6% | – |
| Net Income | -$4,063 | -$4,185 | -$3,623 | -$3,176 |
| % Margin | – | – | -4,355.5% | – |
| EPS Diluted | -1.32 | -1.36 | -1.72 | -1.52 |
| % Growth | 2.9% | 20.9% | -13.2% | – |
| Operating Cash Flow | -$2,656 | -$3,903 | -$3,194 | -$4,132 |
| Capital Expenditures | $0 | -$2 | -$1 | $0 |
| Free Cash Flow | -$2,656 | -$3,905 | -$3,195 | -$4,132 |